close

Digital Health Interventions

News

14.07.2025 - 14:00

Announcing CDHI’s new Scientific Director, Dr. Marcia Nißen

Show newsnorth_east
08.07.2025 - 16:05

Thesis Topic: Linguistic Biomarkers for People with Dementia

Show newsnorth_east
06.07.2025 - 16:33

ELIAS: An Agentic Interview Service

Show newsnorth_east
03.07.2025 - 13:57

Scale-IT-up: Advancing Digital Women’s Health, March 2-3 2026, Marbella, Spain

Show newsnorth_east
29.06.2025 - 11:30

UMZH Precision Digital Therapeutics Summer School, 18-22 August 2025, Zurich

Show newsnorth_east
29.06.2025 - 11:29

An Update from Robin Deuber on his Stanford Research Stay

Show newsnorth_east
29.06.2025 - 11:22

Digital Therapeutics, Fall 2025, University of St.Gallen

Show newsnorth_east
29.06.2025 - 10:55

CAS ETH HSG UZH in Digital Health: Therapeutics 2025-2026 – Module 3: Designing a Digital Biomarker

Show newsnorth_east
29.06.2025 - 10:34

CAS ETH in Digital Health 2025-2026 – Module 4: Designing a Just-in-time Adaptive Intervention

Show newsnorth_east

The team of Digital Health Interventions researches and teaches on the question of how health measures can be enforced with the help of digital means. This requires a direct cooperation between the medical and technical sciences.

On the 1st of August 2022, Tobias Kowatsch was appointed Associate Professor for Digital Health Interventions at the Institute for Implementation Science in Health Care at the Medical Faculty of the University of Zurich. In addition, he became a member of the Directorate of the School of Medicine at the University of St.Gallen. Since 2013 Dr Kowatsch has been the scientific director of the Centre for Digital Health Intervention (CDHI), a joint initiative of the Department of Management, Technology and Economics at ETH Zurich, the Institute of Technology Management at the University of St.Gallen and, newly from August 2022, also of the Institute for Implementation Science in Health Care and the HSG School of Medicine. Furthermore, from 2015 to 2023 Prof. Dr. Kowatsch was scientific director of the CSS Health Lab, a collaboration with the Swiss health insurance company CSS.

Professor Kowatsch teaches and conducts research in the field of digital therapeutics (DTx) at the inter-face of medicine, technology and management. He pursues the following strategic goals:

  1. develop evidence-based DTx for the prevention and management of non-communicable diseases and mental illness. 
  2. develop digital biomarkers for the prevention of critical health conditions. 
  3. facilitate access to health services for vulnerable populations and minorities.


These objektives will be achieved through:

  1. national and international research projects in collaboration with academia, patient organizations, and other public and private healthcare organizations (research).
  2. teaching courses in the field of digital therapeutics, digital biomarkers and digital clinical trials (e.g. Joint Medical Master JMM-HSG/UZH) (teaching & continuing education)
  3. establishment of a globally scalable DTx design & trial service (service)
  4. establishment of an accelerator programme for DTx (start-up funding)

Awards

Academic GIFts

 

north